Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Non Operating Income (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Non Operating Income readings, the most recent being $6.1 million for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 633.21% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1000.0, a 99.81% decrease, with the full-year FY2024 number at $523000.0, up 112.5% from a year prior.
  • Non Operating Income hit $6.1 million in Q4 2025 for Lucid Diagnostics, up from $1.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.9 million in Q2 2025 to a low of -$14.4 million in Q1 2025.
  • Median Non Operating Income over the past 5 years was $28000.0 (2022), compared with a mean of -$223052.6.
  • The widest YoY moves for Non Operating Income: up 4975.0% in 2023, down 193100.0% in 2023.
  • Lucid Diagnostics' Non Operating Income stood at -$65000.0 in 2021, then surged by 172.31% to $47000.0 in 2022, then surged by 1225.53% to $623000.0 in 2023, then surged by 33.87% to $834000.0 in 2024, then soared by 633.21% to $6.1 million in 2025.
  • The last three reported values for Non Operating Income were $6.1 million (Q4 2025), $1.4 million (Q3 2025), and $6.9 million (Q2 2025) per Business Quant data.